⌘K

Home/Filings/4/0000950170-23-014838

4//SEC Filing

AHMED NADIM 4

Accession 0000950170-23-014838

CIK 0001789972other

View on SEC.gov Company Profile

Filed

Apr 25, 8:00 PM ET

Accepted

Apr 26, 4:23 PM ET

Size

4.7 KB

Accession

0000950170-23-014838

Insider Transaction Report

Form 4

Period: 2023-04-25

Cullinan Oncology, Inc.CGEM

DirectorPresident and CEO

Transactions

Sale
Common Stock
2023-04-25$10.59/sh−716$7,582→ 117,288 total

Footnotes (1)

[F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Cullinan Oncology, Inc.

CIK 0001789972

Entity typeother

Related Parties

1

filerCIK 0001731193

Filing Metadata

Form type: 4
Filed: Apr 25, 8:00 PM ET
Accepted: Apr 26, 4:23 PM ET
Size: 4.7 KB

View on SEC.gov